Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8122)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2019 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Santopaolo F, Lenci I, Milana M, Manzia TM, Baiocchi L. Liver transplantation for hepatocellular carcinoma: Where do we stand? World J Gastroenterol 2019; 25(21): 2591-2602 [PMID: 31210712 DOI: 10.3748/wjg.v25.i21.2591] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i21/2591.htm |
| Number | Citing Articles |
| 1 |
Tommy Ivanics, Chaya Shwaartz, Marco P. A. W. Claasen, Madhukar S. Patel, Peter Yoon, Nathanael Raschzok, David Wallace, Hala Muaddi, Carla Fiorella Murillo Perez, Bettina E. Hansen, Nazia Selzner, Gonzalo Sapisochin. Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study. Transplant International 2021; 34(8): 1444 doi: 10.1111/tri.13903
|
| 2 |
Swati Katoch, Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World Journal of Gastroenterology 2022; 28(28): 3535-3554 doi: 10.3748/wjg.v28.i28.3535
|
| 3 |
Yinuo Li, Shosei Shimizu, Masashi Mizumoto, Takashi Iizumi, Haruko Numajiri, Hirokazu Makishima, Gong Li, Hideyuki Sakurai. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation. Cureus 2022; doi: 10.7759/cureus.25744
|
| 4 |
Sehrish Imtiaz, Adnan Yaqoob, Sadia Khan. Nurses’ Performance Regarding Care of Patients Undergone Liver Transplantation: A Comparative Cross-Sectional Study. Pakistan Journal of Health Sciences 2022; : 57 doi: 10.54393/pjhs.v3i07.387
|
| 5 |
Patrick Gidley, Anand Patel, Guliz A. Barkan, Anugayathri Jawahar. An Atypical Presentation of Hepatocellular Carcinoma with Multisite Metastasis following a Curative Liver Transplant. Indian Journal of Radiology and Imaging 2023; 33(03): 420 doi: 10.1055/s-0043-1767694
|
| 6 |
Pablo Martínez-Blanco, Miguel Suárez, Sergio Gil-Rojas, Ana María Torres, Natalia Martínez-García, Pilar Blasco, Miguel Torralba, Jorge Mateo. Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial Intelligence. Diagnostics 2024; 14(4): 406 doi: 10.3390/diagnostics14040406
|
| 7 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 541 doi: 10.4251/wjgo.v13.i7.541
|
| 8 |
Fariba Abbassi, Daniel Gero, Xavier Muller, Alba Bueno, Wojciech Figiel, Fabien Robin, Sophie Laroche, Benjamin Picard, Sadhana Shankar, Tommy Ivanics, Marjolein van Reeven, Otto B. van Leeuwen, Hillary J. Braun, Diethard Monbaliu, Antoine Breton, Neeta Vachharajani, Eliano Bonaccorsi Riani, Greg Nowak, Robert R. McMillan, Samir Abu-Gazala, Amit Nair, Rocio Bruballa, Flavio Paterno, Deborah Weppler Sears, Antonio D. Pinna, James V. Guarrera, Eduardo de Santibañes, Martin de Santibañes, Roberto Hernandez-Alejandro, Kim Olthoff, R Mark Ghobrial, Bo-Göran Ericzon, Olga Ciccarelli, William C. Chapman, Jean-Yves Mabrut, Jacques Pirenne, Beat Müllhaupt, Nancy L. Ascher, Robert J. Porte, Vincent E. de Meijer, Wojciech G. Polak, Gonzalo Sapisochin, Magdy Attia, Olivier Soubrane, Emmanuel Weiss, René A. Adam, Daniel Cherqui, Karim Boudjema, Krzysztof Zieniewicz, Wayel Jassem, Philipp Dutkowski, Pierre-Alain Clavien. Novel Benchmark Values for Redo Liver Transplantation. Annals of Surgery 2022; 276(5): 860 doi: 10.1097/SLA.0000000000005634
|
| 9 |
Michelle R. Ju, John D. Karalis, Matthieu Chansard, M. Mathew Augustine, Eric Mortensen, Sam C. Wang, Matthew R. Porembka, Herbert J. Zeh, Adam C. Yopp, Patricio M. Polanco. Variation of Hepatocellular Carcinoma Treatment Patterns and Survival Across Geographic Regions in a Veteran Population. Annals of Surgical Oncology 2022; 29(13): 8413 doi: 10.1245/s10434-022-12390-7
|
| 10 |
Anil Arora, Ashwani K. Singal, Praveen Sharma, Ashish Kumar. A proposed five-step simplified algorithm for the management of hepatocellular carcinoma in India. Current Medicine Research and Practice 2022; 12(5): 224 doi: 10.4103/cmrp.cmrp_69_22
|
| 11 |
Xiao Wu, Michael Heller, Allison Kwong, Nicholas Fidelman, Neil Mehta. Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates. Journal of Vascular and Interventional Radiology 2023; 34(7): 1237 doi: 10.1016/j.jvir.2023.02.016
|
| 12 |
Tommaso Maria Manzia, Roberta Angelico, Carlo Gazia, Ilaria Lenci, Martina Milana, Oludamilola T Ademoyero, Domiziana Pedini, Luca Toti, Marco Spada, Giuseppe Tisone, Leonardo Baiocchi. <i>De novo</i> malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature. World Journal of Gastroenterology 2019; 25(35): 5356-5375 doi: 10.3748/wjg.v25.i35.5356
|
| 13 |
Mohamed Hassin Mohamed Chairi, Mónica Mogollón González, Alejandro José Pérez Alonso, Mireia Domínguez Bastante, María De Los Ángles Herrero Torres, Carmen Acosta Gallardo, Antonio Palomeque Jiménez. Liver Transplantation in Patients With Hepatocellular Carcinoma: Long-Term Survival Results. Transplantation Proceedings 2022; 54(1): 48 doi: 10.1016/j.transproceed.2021.09.065
|
| 14 |
Hu Bowen, Guo Wenzhi, Wen Peihao, Shi Jihua, Zhang Shuijun. The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1035722
|
| 15 |
Mamatha Bhat, Madhumitha Rabindranath, Beatriz Sordi Chara, Douglas A. Simonetto. Artificial intelligence, machine learning, and deep learning in liver transplantation. Journal of Hepatology 2023; 78(6): 1216 doi: 10.1016/j.jhep.2023.01.006
|
| 16 |
Letizia Todeschini, Luca Cristin, Alessandro Martinino, Amelia Mattia, Salvatore Agnes, Francesco Giovinazzo. The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma. Current Oncology 2023; 30(6): 5574 doi: 10.3390/curroncol30060421
|
| 17 |
Abdullah Altaf, Ahmed Mustafa, Abdullah Dar, Rashid Nazer, Shahzad Riyaz, Atif Rana, Abu Bakar Hafeez Bhatti. Artificial intelligence–based model for the recurrence of hepatocellular carcinoma after liver transplantation. Surgery 2024; 176(5): 1500 doi: 10.1016/j.surg.2024.07.039
|
| 18 |
Julie K. Heimbach. Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma. Seminars in Liver Disease 2020; 40(04): 358 doi: 10.1055/s-0040-1709492
|
| 19 |
Darren J. H. Tan, Chloe Wong, Cheng Han Ng, Chen Wei Poh, Sneha Rajiv Jain, Daniel Q. Huang, Mark D. Muthiah. A Meta-Analysis on the Rate of Hepatocellular Carcinoma Recurrence after Liver Transplant and Associations to Etiology, Alpha-Fetoprotein, Income and Ethnicity. Journal of Clinical Medicine 2021; 10(2): 238 doi: 10.3390/jcm10020238
|
| 20 |
Li Liu, Xianxian Liang, Xiangxian Xu, Xiang Zhang, Jun Wen, Kun Chen, Xiaodan Su, Zhaogang Teng, Guangming Lu, Jian Xu. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer. Acta Biomaterialia 2021; 130: 374 doi: 10.1016/j.actbio.2021.05.031
|
| 21 |
Jacob Zaemes, Muneeb Rehman, Coleman Smith, Ruth He. Immune Checkpoint Inhibitors - New Insights and Recent Progress. 2023; doi: 10.5772/intechopen.107097
|
| 22 |
Kelly Casler, Amanda Chaney. Cirrhosis. Nursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
|
| 23 |
Junfeng Ye, Yu Fu, Zhongfeng Wang, Jinhai Yu. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2. Cell Biology and Toxicology 2022; 38(6): 1047 doi: 10.1007/s10565-021-09642-9
|
| 24 |
Qing-Shuai Ren, Qiu Sun, Shu-Qin Cheng, Li-Ming Du, Ping-Xuan Guo. Hepatocellular carcinoma: An analysis of the expression status of stress granules and their prognostic value. World Journal of Gastrointestinal Oncology 2024; 16(6): 2571-2591 doi: 10.4251/wjgo.v16.i6.2571
Abstract(153) |
Core Tip(157) |
Full Article(HTML)(947)
|
Full Article with Cover (PDF)-10737K(33)
|
Audio-5447K(4)
|
Peer-Review Report-172K(16)
|
Answering Reviewers-117K(23)
|
Supplementary Material-53K(27)
|
Full Article (PDF)-10426K(47)
|
Full Article (XML)-182K(21)
|
Times Cited (0)
|
Total Visits (1941)
|
Open
|
| 25 |
Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi, Alessandro Granito. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9926704
|
| 26 |
Khalid I. Bzeizi, Maheeba Abdullah, Kota Vidyasagar, Saleh A. Alqahthani, Dieter Broering. Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence. Cancers 2022; 14(20): 5114 doi: 10.3390/cancers14205114
|
| 27 |
Paulo Ricardo Gessolo Lins, Roberto Camargo Narciso, Leonardo Rolim Ferraz, Virgilio Gonçalves Pereira, Ben-Hur Ferraz-Neto, Marcio Dias De Almeida, Bento Fortunato Cardoso Dos Santos, Oscar Fernando Pavão Dos Santos, Júlio Cesar Martins Monte, Marcelino Souza Durão Júnior, Marcelo Costa Batista. Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation. BMC Nephrology 2022; 23(1) doi: 10.1186/s12882-022-02912-6
|
| 28 |
Mark P. Dumago, Ryan Anthony F. Agas, Carl Jay E. Jainar, Eugene T. Yap, Lester Bryan A. Co, Teresa T. Sy Ortin. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2023; 54(4): 1058 doi: 10.1007/s12029-023-00940-5
|
| 29 |
Maria Tampaki, George V. Papatheodoridis, Evangelos Cholongitas. Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview. Cancers 2023; 15(4): 1310 doi: 10.3390/cancers15041310
|
| 30 |
Alexandre Coutinho Teixeira de Freitas, Fátima Diana Samúdio Espinoza, Cristina Alvarez Mattar, Júlio Cezar Uili Coelho. INDICATION FOR LIVER TRANSPLANTATION DUE TO HEPATOCELLULAR CARCINOMA: ANALYSIS OF 1,706 PROCEDURES OVER THE PAST DECADE IN THE STATE OF PARANÁ. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2022; 35 doi: 10.1590/0102-672020220002e1701
|
| 31 |
Vladimir J Lozanovski, Ali Ramouz, Ehsan Aminizadeh, Sadeq Ali-Hasan Al-Saegh, Elias Khajeh, Heike Probst, Susanne Picardi, Christian Rupp, De-Hua Chang, Pascal Probst, Arianeb Mehrabi. Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis. BJS Open 2022; 6(1) doi: 10.1093/bjsopen/zrab130
|
| 32 |
Mingxin Cui, Fengzhi Qu, Libing Wang, Xiaogang Liu, Jingkun Yu, Zhaoyuan Tang, Daming Cheng. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomarkers 2022; 33(3): 389 doi: 10.3233/CBM-210154
|
| 33 |
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Current Issues in Molecular Biology 2024; 46(6): 5965 doi: 10.3390/cimb46060356
|
| 34 |
Satoshi Omiya, Shohei Komatsu, Kazuki Terashima, Nobuaki Yamasaki, Yoshiro Matsuo, Hirochika Toyama, Sunao Tokumaru, Tomoaki Okimoto, Takumi Fukumoto. Hepatic Resection vs Particle Therapy as an Initial Treatment for Single Hepatocellular Carcinoma: Bi-institutional Propensity Score–Matched Analysis. Journal of the American College of Surgeons 2023; 236(5): 972 doi: 10.1097/XCS.0000000000000532
|
| 35 |
Yi Duan, Yuanyuan Meng, Zhifeng Gao, Xiaoyu Wang, Huan Zhang. microRNA-9-5p protects liver sinusoidal endothelial cell against oxygen glucose deprivation/reperfusion injury. Open Life Sciences 2021; 16(1): 375 doi: 10.1515/biol-2021-0042
|
| 36 |
Mayank Garg, Saumya Johri, Krishnendu Chakraborty. Immunomodulatory role of mitochondrial DAMPs: a missing link in pathology?. The FEBS Journal 2023; 290(18): 4395 doi: 10.1111/febs.16563
|
| 37 |
Gerardo Sarno, Roberto Montalti, Mariano Cesare Giglio, Gianluca Rompianesi, Federico Tomassini, Emidio Scarpellini, Giuseppe De Simone, Giovanni Domenico De Palma, Roberto Ivan Troisi. Hepatocellular carcinoma in patients with chronic renal disease: Challenges of interventional treatment. Surgical Oncology 2021; 36: 42 doi: 10.1016/j.suronc.2020.11.007
|
| 38 |
Patricia Holanda Almeida, Celso E L Matielo, Lilian A Curvelo, Rodrigo A Rocco, Guilherme Felga, Bianca Della Guardia, Yuri L Boteon. Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology 2021; 27(23): 3249-3261 doi: 10.3748/wjg.v27.i23.3249
|
| 39 |
Jia-Jia He, Lei Shang, Qun-Wei Yu, Ning Jiao, Shuang Qiu, Wei-Xiong Zhu, Dong-Feng Wu, Yun-Er Tian, Qing Zhang. High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology 2021; 13(7): 716-731 doi: 10.4251/wjgo.v13.i7.716
|
| 40 |
Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Renata Glehn-Ponsirenas, Gennaro Selvaggi, Akin Tekin, Christopher B. O’Brien, Lynn Feun, Rodrigo Vianna, Phillipe Abreu. Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant. Cancers 2023; 15(12): 3165 doi: 10.3390/cancers15123165
|
| 41 |
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, Ashlie Santaliz-Casiano, Zeynep Madak-Erdogan. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style. Steroids 2024; 203: 109330 doi: 10.1016/j.steroids.2023.109330
|
| 42 |
Cody R Criss, Mina S Makary. Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(3): 413-424 doi: 10.3748/wjg.v29.i3.413
|
| 43 |
Xueyan Lin, Yi Lin, Zhihui Lin, Juan Chen. Cost-Effectiveness of First-Line Nucleos(T)Ide Analogs for Treatment of Chronic Hepatitis B in China with New Volume-Based Purchasing Policy. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4060774
|
| 44 |
Maria Gonçalves-Reis, Daniela Proença, Laura P. Frazão, João L. Neto, Sílvia Silva, Hugo Pinto-Marques, José B. Pereira-Leal, Joana Cardoso. Analytical validation and algorithm improvement of HepatoPredict kit to assess hepatocellular carcinoma prognosis before a liver transplantation. Practical Laboratory Medicine 2024; 39: e00365 doi: 10.1016/j.plabm.2024.e00365
|
| 45 |
凌 于. Research Progress of Medical Imaging Predictions of HCC Recurrence after Treatment. Advances in Clinical Medicine 2024; 14(10): 632 doi: 10.12677/acm.2024.14102706
|
| 46 |
Emily A. Thompson, Megan C. Jacobsen, David T. Fuentes, Rick R. Layman, Erik N. K. Cressman. Quantitative dual‐energy computed tomography with cesium as a novel contrast agent for localization of thermochemical ablation in phantoms and ex vivo models. Medical Physics 2023; 50(12): 7879 doi: 10.1002/mp.16558
|
| 47 |
Cagla Tekin, Melis Ercelik, Secil Ak Aksoy, Mine Camlibel, Sena Ferah, Melisa Gurbuz, Fuat Aksoy, Ekrem Kaya, Berrin Tunca. Investigation of the Effectiveness of Oleuropein in a Three-Dimensional In Vitro Hepatocellular Tumor Sphere Model. Experimental and Clinical Transplantation 2023; 21 doi: 10.6002/ect.2023.0020
|
| 48 |
Hua Liu, Jing Cheng, Heng Xu, Zhenzhen Wan. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis. Open Life Sciences 2021; 16(1): 766 doi: 10.1515/biol-2021-0072
|
| 49 |
Preston Kim, Michael Littau, Talia B. Baker, Zaid Abdelsattar, Celsa Tonelli, Corinne Bunn, Sujay Kulshrestha, Fred A. Luchette, Marshall S. Baker. Intrahepatic cholangiocarcinoma: Is there a role for liver transplantation?. Surgery 2022; 171(3): 741 doi: 10.1016/j.surg.2021.09.034
|
| 50 |
Piter J. Bosma, Marius Wits, Ronald P. J. Oude-Elferink. Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects. International Journal of Molecular Sciences 2020; 22(1): 273 doi: 10.3390/ijms22010273
|
| 51 |
Magdelyn Mei-Theng Wong, Hui-Yin Chan, Norazlin Abdul Aziz, Thamil Selvee Ramasamy, Jan-Jin Bong, Ewe Seng Ch’ng, Subasri Armon, Suat-Cheng Peh, Sin-Yeang Teow. Interplay of autophagy and cancer stem cells in hepatocellular carcinoma. Molecular Biology Reports 2021; 48(4): 3695 doi: 10.1007/s11033-021-06334-9
|
| 52 |
Allison N. Devitt, Abigail L. Vargas, Wei Zhu, Benjamin James Des Soye, Fatma Ayaloglu Butun, Tyler Alt, Nicholas Kaley, Glaucio M. Ferreira, Graham R. Moran, Neil L. Kelleher, Dali Liu, Richard B. Silverman. Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase. ACS Chemical Biology 2024; 19(5): 1066 doi: 10.1021/acschembio.4c00022
|
| 53 |
M.H. Mohamed-Chairi, A.B. Vico-Arias, N. Zambudio-Carroll, M.T. Villegas-Herrera, J.M. Villar-del-Moral. Análisis comparativo de pacientes trasplantados por carcinoma hepatocelular. ¿Hay diferencias en cuanto a supervivencia entre los que cumplen criterios de Milán y los que los exceden?. Revista de Gastroenterología de México 2024; doi: 10.1016/j.rgmx.2024.06.003
|
| 54 |
Jun-cheng Guo, Yi-jun Yang, Min Guo, Jian-quan Zhang, Jin-fang Zheng, Zhuo Liu. Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells. Cancer Gene Therapy 2021; 28(10-11): 1136 doi: 10.1038/s41417-020-00261-w
|
| 55 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 321 doi: 10.1002/9781119756422.ch18
|
| 56 |
Dobrochna Dolicka, Michelangelo Foti, Cyril Sobolewski. The Emerging Role of Stress Granules in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(17): 9428 doi: 10.3390/ijms22179428
|
| 57 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
| 58 |
Dora C. Huang, Rosa L. Yu, Saleh Alqahtani, Hani Tamim, Behnam Saberi, Alan Bonder. Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma. Annals of Hepatology 2023; 28(5): 101127 doi: 10.1016/j.aohep.2023.101127
|
| 59 |
Madhumitha Rabindranath, Amirhossein Azhie, Mamatha Bhat. Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases. 2023; : 195 doi: 10.1016/B978-0-323-99136-0.00017-9
|
| 60 |
Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour. What Is the Role of Body Composition Assessment in HCC Management?. Cancers 2022; 14(21): 5290 doi: 10.3390/cancers14215290
|
| 61 |
Claire Durkin, Therese Bittermann. Liver transplantation for alcohol-associated hepatitis. Current Opinion in Organ Transplantation 2022; doi: 10.1097/MOT.0000000000001044
|
| 62 |
Veysel Ersan, Bora Barut, Sezai Yilmaz. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?. Journal of Gastrointestinal Cancer 2020; 51(4): 1152 doi: 10.1007/s12029-020-00491-z
|
| 63 |
Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man. External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation. Cancers 2022; 14(3): 630 doi: 10.3390/cancers14030630
|
| 64 |
Zhe Yang, Shuo Wang, Xin-Yao Tian, Qin-Fen Xie, Li Zhuang, Qi-Yong Li, Cheng-Ze Chen, Shu-Sen Zheng. Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience. Hepatobiliary & Pancreatic Diseases International 2020; 19(4): 365 doi: 10.1016/j.hbpd.2020.06.002
|
| 65 |
Ankita Srivastava, Alexandra Manchel, John Waters, Manju Ambelil, Benjamin K. Barnhart, Jan B. Hoek, Ashesh P. Shah, Rajanikanth Vadigepalli. Integrated transcriptomics and histopathology approach identifies a subset of rejected donor livers with potential suitability for transplantation. BMC Genomics 2024; 25(1) doi: 10.1186/s12864-024-10362-7
|
| 66 |
Amirhossein Azhie, Robert C Grant, Michael Herman, Lisa Wang, Jennifer J Knox, Mamatha Bhat. Phase II clinical trial of cabozantinib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Future Oncology 2022; 18(18): 2173 doi: 10.2217/fon-2021-1635
|
| 67 |
Shan Zhang, Zhong-Wei Chen, Shi-Min Meng, Qing-Lin Ding, Zhi-Biao Zhong, Yan-Hong Wei, Qi-Fa Ye, Kang-Hong Hu. Eukaryotic initiation factor 3e subunit is positively associated with tumorigenesis and development of hepatocellular carcinoma. World Chinese Journal of Digestology 2020; 28(12): 475 doi: 10.11569/wcjd.v28.i12.475
|
| 68 |
Wilhelm den Toom, Eva M. Negenman, Francois E.J.A. Willemssen, Erik van Werkhoven, Robert J. Porte, Roeland F. de Wilde, Dave Sprengers, Imogeen E. Antonisse, Ben J.M. Heijmen, Alejandra Méndez Romero. Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma. Clinical and Translational Radiation Oncology 2024; 49: 100878 doi: 10.1016/j.ctro.2024.100878
|
| 69 |
Liqing Zhang, Zhaodan Ye, Liren Lu, Jianfeng Xu. Is DEB-TACE as locoregional therapy before liver transplantation for hepatocellular carcinoma effective?. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03434-1
|
| 70 |
Gregory Kenneth Muliawan, Terence Kin-Wah Lee. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1400112
|
| 71 |
Amit Kumar Singh, Shiv Vardan Singh, Ramesh Kumar, Shashank Kumar, Sabyasachi Senapati, Abhay K Pandey. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise . World Journal of Hepatology 2023; 15(1): 1-18 doi: 10.4254/wjh.v15.i1.1
|
| 72 |
Hamzah Adwan, Lars Hammann, Thomas J. Vogl. Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection. Journal of Clinical Medicine 2023; 12(7): 2560 doi: 10.3390/jcm12072560
|